Life Sciences Funding Opportunities

    Last updated: 02/15/19. For additional funding resources, please see available funding on the EVPRP website


    Purdue Institute for Integrative Neuroscience

    Funding Opportunity

    Award Amount

    Deadline

    Klingenstein-Simons Fellowship Awards in Neuroscience

    $225,000

    February 15, 2019

    CART Fund Alzheimer’s Research

    $250,000

    February 22, 2019

    Organization for Autism Research Applied Research Competition

    Up to $40,000

    Pre-Prop: March 25, 2019
    (Full Prop by invitation)

    NIH Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54)

    Up to $2,250,000

    April 10, 2019

    The Franklin Institute’s Bower Award & Prize for Achievement in Science

    $250,000

    April 30, 2019

    NSF/NIH A Science of Science Policy Approach to Analyzing and Innovating the Biomedical Research Enterprise  (SCISIPBIO)

    Varies

    May 8, 2019

    NIH Summer Research Education Experience Program (R25)

    Varies

    May 25, 2019

    NIH High-End Instrumentation (HEI) Grant Program (S10) 

    $2,000,000

    May 31, 2019

    NIH Shared Instrumentation Grant (SIG) Program (S10)

    $600,000

    May 31, 2019

    Whitehall Foundation Grants for Bioscience Research Projects

    $30,000 - $75,000

    June 1, 2019

    NSF Science of Learning

    Varies

    July 10, 2019

    Purdue Institute of Inflammation, Immunology and Infectious Disease

    Funding Opportunity

    Award Amount

    Deadline

    NIH Notice of Intent to Publish Funding Opportunity Announcements to Promoter Implementation Science (R01) and Dissemination and Implementation Studies (R18)

    Varies

    Calendar Year

    Alfred P. Sloan Foundation 

    Varies

    On-going

    NIH-NIAID Omnibus Broad Agency Announcement

    Varies

    Varies

    Immune Epitope and Analysis Resource Program

    Varies

    Varies

    Trophoblast Differentiation and Function (R21 Clinical Trial Optional)

    Varies

    Varies

    ORAU Higher Education Research Experiences for Faculty at Oak Ridge National Laboratory

    Varies

    On-going

    NIH Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections 
    R01 
    R21

    Varies

     

     

    February 5, 2019
    February 16, 2019

    NIH Advancing Development of Rapid Fungal Diagnostics
    R01
    R21

    Varies

     

    February 5, 2019
    February 16, 2019

    NIH Immuno-Oncology Translational Network (IOTN)

    Immuno-engineering to Improve Immunotherapy (i3) Centers (U54)

    Varies

     

    February 8, 2019
    February 8, 2019

    February 11, 2019

    February 11, 2019

    NIH Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) 

    Varies

    February 11, 2019

    NIH Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21)

    Varies

    February 16, 2019

    NIH Accelerating Malaria Vaccine Discovery (R01)

    Varies

    February 26, 2019

    Varies

    February 27, 2019

    NIH Single-Cell Multi-Omics of HIV Persistence (R01)

    Varies

    March 13, 2019

    NIH Addressing the Role of Violence on HIV Care and Viral Suppression

     

    April 10, 2019

    NIH Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)

    Varies

    May 7, 2019

    NIH High-End Instrumentation (HEI) Grant Program (S10) 

    Varies

    May 31, 2019

    NIH Shared Instrumentation Grant (SIG) Program (S10) 

    Varies

    May 31, 2019

    NIH Computational Models of Immunity (U01) 

    Varies

    June 10, 2019

    NIH Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18)

    Varies

    July 12, 2019

    HHS Office of Biomedical Advanced Research and Development Authority (BARDA) BAA

    Varies

    October 31, 2019

    DOD-CDMRP BAA for Extramural Biomedical Research and Development 

    Varies

    On-going through July 31, 2023

    Purdue Institute for Drug Discovery

    Funding Opportunity

    Award Amount

    Deadline

    DOD-CDMRP Peer Reviewed Medical Research Program  

    Varies

    Rolling

    DOD-CDMRP Breast Cancer

    Varies

    Rolling

    Antibacterial Resistance Leadership Group (ARLG) Collaboration

    Varies

    Rolling

    Alpha-Synuclein Imaging Prize

    2,000,000

    Rolling

    Camille & Henry Dreyfus Foundation Dreyfus Prize in the Chemical Sciences  

    $250,000

    February 28, 2019

    Camille and Henry Dreyfus Foundation’s 2019 Dreyfus Prize in the Chemical Sciences  

    $250,000

    February 28, 2019

    HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain - (U44 )

    $8,250,000

    March 6, 2019

    NIH Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21)

    Varies

    March 7, 2019

    NIH Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)

    $400,000

    March 7, 2019

    NIH U.S.-Brazil Collaborative Biomedical Research Program (R01)  

    Varies

    March 8, 2019

    NIH Genetic Engineering Technologies for HIV Cure Research (U19)  

    Varies

    March 11, 2019

    NIH Single-Cell Multi-Omics of HIV Persistence (R01)  

    Varies

    March 13, 2019

    NIH Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01)

    Varies

    March 14, 2019

    HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3)

    Varies

    March 22, 2019

    HEAL Initiative: Translational Development of Devices to Treat Pain (U18)

    $1,500,000

    March 22, 2019

    Amyotrophic Lateral Sclerosis Research Program (ALSRP) - Therapeutic Development Award

    $1,000,000

    March 22, 2019

    Amyotrophic Lateral Sclerosis Research Program (ALSRP) - Therapeutic Idea Award

    $500,000

    March 22, 2019

    HHS-FDA Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01)  

    Varies

    April 11, 2019

    HHS-FDA Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal, Anal or Rectal Dosage Forms (U01)

    Varies

    April 11, 2019

    Cottrell Scholar Award  

    $100,000

    Preproposal April 15, 2019

    NIH Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)

    Varies

    May 7, 2019

    NIH Shared Instrumentation Grant (SIG) Program (S10)

    $600,000

    May 31, 2019

    NIH High-End Instrumentation (HEI) Grant Program (S10)

    $2,000,000

    May 31, 2019

    Serious Adverse Drug Reaction Research (R01)

    Varies

    June 1, 2019

    NIH Biology of Bladder Cancer  (R01)

    Varies

    June 5, 2019

    NIH Biology of Bladder Cancer (R01)

    Varies

    June 5, 2019

    Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)

    Varies

    June 5, 2019

    Advancing Basic Neurobiology Toward Translation Through Assay Development (R01)

    Varies

    June 5, 2019

    NIH Computational Models of Immunity (U01)

    Varies

    June 10, 2019

    Drug Discovery For Nervous System Disorders (R01)

    Varies

    June 5, 2019

    NIH Biology of Bladder Cancer  (R21)

    $275,000

    June 15, 2019

    NIH Biology of Bladder Cancer  (R21)

    $275,000

    June 16, 2019

    Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)

    Varies

    June 25, 2019

    Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3)

    Varies

    August 9, 2019

    Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)

    $300,000

    September 10, 2019

    Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)

    Varies

    September 10, 2019

    Purdue University Institute for Plant Sciences

    Funding Opportunity

    Award Amount

    Deadline

    Specialty Crop Research Initiative (SCRI)

    $80,000,000

    December 10, 2018

    https://www.nifa.usda.gov/funding-opportunity/food-and-agricultural-sciences-national-needs-graduate-and-postgraduate

    $37,000 - $262,500

    January 23, 2019

    NSF Dear Colleague Letter: Request for Information - Integration Institutes for Cross-cutting Biology
    BIO-RFI-II@nsf.gov
    Request for Information - Integration Institutes for Cross-cutting Biology
    Span multiple levels of organization in living systems and require expertise from diverse biological subdisciplines

     

    March 1, 2019

    Purdue Center for Cancer Research

    Funding Opportunity

    Deadline

    NIH Funding Opportunities

     

    NIH U.S.-China Program for Biomedical Collaborative Research (R01)

    February 21, 2019

    NIH Alzheimer's-focused administrative supplements for NIH grants that are not focused on Alzheimer's disease

    February 26, 2019

    NIH Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors  This initiative will support exploratory and developmental multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations.
    R01  Deadline:  March 4
    R21  Deadline:  March 4

    March 4, 2019

    NIH Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21)

    March 7, 2019

    NIH Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)   

    March 7, 2019

    NIH Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)

    March 7, 2019

    NIH Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)

    March 7, 2019

    NIH Biology of Bladder Cancer  This FOA encourages applications investigating the biology and underlying mechanisms of bladder cancer. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer. Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.

    • R01 Deadline:  June 5
    • R21 Deadline:  June 16

    Varies

    NIH Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01)

    August 1, 2019

    NIH Notice of Intent to Publish a FOA for Diversity Program Consortium Dissemination and Translation Awards (U01)

    July 1, 2020

    NIH Administrative Supplements to Existing NIH Grants and Cooperative Agreements.  The National Institutes of Health (NIH) hereby notify Program Directors/Principal Investigators (PD(s)/PI(s)) holding specific types of NIH research grants listed in the full Funding Opportunity Announcement (FOA) that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. 

    Varies by awarding IC

    Other Cancer Funding Opportunities

    Funding Opportunity

    Deadline

    Camille and Henry Dreyfus Foundation’s 2019 Dreyfus Prize in the Chemical Sciences  The Dreyfus Prize, awarded biennially, recognizes an individual for exceptional and original research in a selected area of chemistry that has advanced the field in a major way. The prize consists of a monetary award of $250,000, a medal, and a certificate.  This year’s theme is Chemistry in Support of Human Health.  Any person may nominate a candidate for the Dreyfus Prize. Self-nominations are not accepted. 

    February 28, 2019

    NSF Biophotonics 

    On-going through August 15, 2019

    NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB)  

    On-going

    DOE-JGI CSP New Investigator 

    On-going

    NSF Big Ideas updates

    Varies

    DOD-CDMRP Peer Reviewed Medical Research Program  The program includes several mechanisms including:  Discovery Award; Focused Program Award; Investigator-Initiated Research Award, and Technology/Therapeutic Development Award. 

    Varies

    DOD-CDMRP Breast Cancer

    Varies

    The AACR is currently accepting applications for the following opportunities:
    Grants for mentored researchers in the areas of lung, ovarian, pediatric, and breast cancer research, lymphoma, myeloma, and all areas of clinical and translational cancer research
    A grant for tenure-eligible junior faculty focused on any area of cancer research
    A grant for established investigators in the field of neuroendocrine tumor research
    Learn More
    Apply Now

    Varies

    Limited Submissions
    Purdue Internal Deadlines for Proposals
    Numerous new opportunities, follow link for details

    Varies

    The Fiscal Year 2019 (FY19) Defense Appropriation Act provides funding for the peer reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP). This e-mail is to notify the research community of recently released pre-announcements (http://cdmrp.army.mil/pubs/press/press) to allow investigators time to plan and develop ideas for submission to the anticipated FY19 funding opportunities.  

    FY19 funding opportunities are anticipated to be released in January 2019 for the following programs:

    Breast Cancer Research Program
    Ovarian Cancer Research Program

    Descriptions of each of the anticipated funding opportunities, eligibility, key mechanism elements, and funding can be found in the respective Program pre-announcement.  FY19 pre-announcements can be found in the CDMRP home page features at http://cdmrp.army.mil.

    Varies

    Peer Reviewed Medical Research Program
    Clinical Trial Award
    Discovery Award
    Focused Program Award
    Investigator-Initiated Research Award
    Technology/Therapeutic Development Award

    Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements. The Program Announcements are available electronically for downloading from the Grants.gov website (http://www.grants.gov), the CDMRP website (https://cdmrp.army.mil/funding/default) and the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org).

    All CDMRP funding opportunities, both recently and previously released, are available on the CDMRP website (https://cdmrp.army.mil).

    Subsequent notifications will be sent when additional funding opportunities are released. A listing of all open CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

    Submission is a two-step process requiring both pre-application submission and full application submission.  All pre-applications must be submitted through eBRAP (https://eBRAP.org/).  Full applications from extramural organizations (non-DoD organizations) must be submitted through Grants.gov (http://www.grants.gov/).  Intramural DoD organizations may submit full applications to either eBRAP or Grants.gov.  Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov.  For detailed information on the submission process, refer to Section II.D. of the Program Announcement/Funding Opportunity.

    eBRAP is a multifunctional web-based system that allows PIs to submit their pre-applications electronically through a secure connection, to view and edit the content of their pre-applications and full applications, to receive communications from the CDMRP, and to submit documentation during award negotiations and period of performance.  A key feature of eBRAP is the ability of an organization’s representatives and PIs to view and modify the Grants.gov application submissions associated with them.  eBRAP will validate Grants.gov application files against the specific Program Announcement/Funding Opportunity requirements and discrepancies will be noted in an email to the PI and in the Full Application Files tab in eBRAP.  It is the applicant’s responsibility to review all application components for accuracy as well as ensure proper ordering as specified in this Program Announcement/Funding Opportunity. 

    Varies

    Purdue University, West Lafayette, IN 47907 (765) 494-4600

    © 2019 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by Office of the Executive Vice President for Research and Partnerships

    If you have trouble accessing this page because of a disability, please contact Office of the Executive Vice President for Research and Partnerships at evprp@purdue.edu.